Introduction {#s1}
============

Seminal clinical studies have recently shown that transplantation of stem cells, genetically modified by retroviral vectors, may cure severe genetic diseases such as immunodeficiencies [@pcbi.1002292-Aiuti1], [@pcbi.1002292-HaceinBeyAbina1], skin adhesion defects [@pcbi.1002292-Mavilio1] and lysosomal storage disorders [@pcbi.1002292-Cartier1]. Unfortunately, some of these studies also showed the limitations of retroviral gene transfer technology, which may cause severe and sometimes fatal adverse effects. In particular, insertional activation of proto-oncogenes by vectors derived from the Moloney murine leukemia virus (MLV) caused T-cell lymphoproliferative disorders in five patients undergoing gene therapy for X-linked severe combined immunodeficiency [@pcbi.1002292-HaceinBeyAbina2], [@pcbi.1002292-Howe1], and pre-malignant expansion of myeloid progenitors in two patients treated for chronic granulomatous disease [@pcbi.1002292-Ott1]. Pre-clinical experiments showed that HIV-derived lentiviral vectors are less likely to cause insertional gene activation than MLV vectors. Most of the studies on retroviral integration preferences, however, have been carried out on cell lines that poorly represent the genomic characteristics of somatic stem cells, or on limited numbers of patient-derived cells. A better understanding of the interactions between retroviral vectors and the genome of clinically relevant target cells may provide a more rational basis for predicting genotoxic risks in clinical gene therapy.

A large number of studies have focused on the molecular mechanisms by which mammalian retroviruses choose their integration sites in the target cell genome. After entering a cell, the retroviral RNA genome is reverse transcribed into double-stranded DNA, and assembled in pre-integration complexes (PICs) containing viral as well as cellular proteins. PICs associate with the host cell chromatin, where the virally encoded integrase mediates proviral insertion in the genomic DNA. Retroviral integration is a non-random process, whereby PICs of different viruses recognize components or features of the host cell chromatin in a specific fashion [@pcbi.1002292-Bushman1]. The LEDGF/p75 protein has been identified as the main factor tethering HIV PICs to active chromatin [@pcbi.1002292-Engelman1], while mechanisms underlying integration site selection of other retroviruses remain largely unknown. We recently showed that MLV-derived vectors integrate preferentially in hotspots near genes involved in the control of growth, differentiation and development of hematopoietic cells and flanked by defined subsets of transcription factor binding sites; this suggested that MLV PICs are tethered to transcriptionally active regulatory regions engaged by basal components of the RNA Pol II transcriptional machinery [@pcbi.1002292-Cattoglio1], [@pcbi.1002292-Felice1]. On the contrary, HIV-derived vectors target expressed genes in their transcribed portions away from regulatory elements, suggesting a different evolutionary strategy for these two viruses.

The molecular basis of retroviral target site selection is still poorly understood. The concept of integration "hotspot" was introduced to describe areas of the genome where integrations accumulate more than expected by chance in the absence of any selection process [@pcbi.1002292-Cattoglio1]. Hotspots therefore differ from "common integration sites" (CIS), which were defined as sites recurrently associated with virus-induced malignant expansion [@pcbi.1002292-Suzuki1]. The final goal in finding hotspots is to investigate genomic properties that lead certain areas to "attract" or "refuse" integration. We suggested in previous work that integration preferences are dependent on the intrinsic gene density distribution and on the type of vector [@pcbi.1002292-Ambrosi1], [@pcbi.1002292-Ambrosi2].

In this paper we develop a statistical methodology to detect "comparative" hotspots, i.e. areas of the genome where integration intensities of MLV and HIV appear to differ. We do not find regions where the viruses prefer to integrate, but where the integration patterns are different. Our approach followed two steps: first candidate comparative hotspots were identified by comparing variability bands around estimated integration intensities along the genome, and then each candidate comparative hotspot was tested in turn. After multiplicity correction we produced a list of 100 comparative hotspots, ready for further biological validation. Our analysis discriminated regions which were targeted by both viruses, most likely on the basis of their accessibility (high content of active genes), from regions specifically that are preferred by either MLV or HIV. We show that HIV and MLV integrate differently in regions spanning 0.2 to \>6 Mb in the human genome, with specific patterns. In particular, HIV-specific hotspots are wider and contain a larger number of genes. The preference of HIV or MLV for these regions cannot be explained by the known viral target site selection preferences, or by the expression characteristics of the targeted genes, suggesting the existence of epigenetic or nuclear topology contexts that drive retroviral integration to specific chromosome territories.

Results {#s2}
=======

We developed a new statistical method to compare the integration preferences of distinct retroviral vectors in the human genome and we used it to analyze a collection of ∼30,000 MLV and HIV-vector insertion sites in human CD34^+^ hematopoietic stem-progenitor cells [@pcbi.1002292-Cattoglio2]. [Figure 1](#pcbi.1002292-g001){ref-type="fig"} illustrates how the methodology performs on chromosome 6. We compared the two integration propensities for each arm and strand separately. The blue 99% variability band corresponds to the integration density of HIV, estimated from our data; in red the band for MLV. When the two bands stay apart, one above the other, a candidate comparative hotspot is identified as the segment of such empty intersection. These are depicted as blue and red thick segments in the center of the plot. In chromosome 6 we identified 12 candidate hotspots where MLV shows more integrations than HIV, and 5 candidate hotspots where HIV is dominating. In most of chromosome 6, we found no differences in integration patterns. Note the high peak of integration on the p-arm for HIV, on both strands, corresponding to the MHC locus. Similar plots for all chromosomes are available in supplementary material [Figure S1](#pcbi.1002292.s001){ref-type="supplementary-material"} and [Figure S2](#pcbi.1002292.s002){ref-type="supplementary-material"}.

![**Integration densities of HIV and MLV in CD34^+^ cells, for chromosome 6.**\
We analyzed each strand separately: the upper half is the + strand and the lower the - strand. In blue the estimated variability band at level 0.99 for HIV integrations (n = 1629), in red for MLV (n = 1815). Candidate comparative hotspots are plotted in the two central *x*-axes, the color indicating which of the two vectors had stronger integration intensity (HIV: blue; MLV: red). In the other four *x*-axes, each tick represents one integration site, with the same color code. Because of resolution, many ticks fall on the same point and cannot be distinguished.](pcbi.1002292.g001){#pcbi.1002292-g001}

The panels of [Figure 2](#pcbi.1002292-g002){ref-type="fig"} show two typical situations in detail. The panel A (left side) from the HIV HLA locus in chromosome 6, arm p; upper panel refers to strand+, lower panel refers to strand -. We see how the estimated variability bands, around the non-parametrically estimated integration densities, are clearly apart from each other. The bands overlap at both ends of the comparative hotspot, which is therefore well defined. The width of the bands describes the statistical uncertainty attached to the estimated densities: in both cases the MLV bands are quite thin, as there are a total large number of integrations. The bands for HIV are larger; the exact density function is difficult to estimate with limited sample size. Despite the uncertainty, the candidate hotspot in panel A is clearly identified. The panels B of [Figure 2](#pcbi.1002292-g002){ref-type="fig"} show a candidate comparative hotspot in the plus strand of chromosome 6, arm q, which has no corresponding in the minus strand. In other locations of the genome, the two bands often overlap simply due to lack of data, rather than because the two vectors are equally distributed. This indicates that our method will leave undiscovered comparative hotspots (false negatives). Not all the candidate comparative hotspots that we identified were clearly distinguishable.

![**Two typical situations in comparative hotspots.**\
In panel A (left side) the bands don\'t overlap in plus and minus strands, suggesting the presence of two candidate comparative hotspots (hotspots ID: hiv_36 and hiv_40, see supplementary material, [Table S1](#pcbi.1002292.s009){ref-type="supplementary-material"}). Differences in integration densities in one versus the other strand may reflect a preferential integration orientation at that particular locus. In panel B (right side) the bands don\'t overlap in the plus strand (upper panel) whereas on the minus strand they do (lower panel), suggesting only one candidate (hotspot ID: mlv_43, see supplementary material, [Table S1](#pcbi.1002292.s009){ref-type="supplementary-material"}). These examples are taken from chromosome 6.](pcbi.1002292.g002){#pcbi.1002292-g002}

Our analysis led to 256 candidate comparative hotspots on all chromosomes (see, supplementary material, [Table S1](#pcbi.1002292.s009){ref-type="supplementary-material"}). Each candidate comparative hotspot was then tested individually. We computed odds ratios, between HIV and MLV odds of integrations in each hotspot, and tested the null hypothesis that the odds ratio is one. P-values were then corrected for multiple testing. This reduced the number of significative comparative hotspot to 100, reported in [Table 1](#pcbi.1002292-t01){ref-type="table"}.

10.1371/journal.pcbi.1002292.t001

###### Comparative Hotspots.

![](pcbi.1002292.t001){#pcbi-1002292-t001-1}

  virus     chr    strand     start        end      length     OR     adjusted-p   \# genes
  ------- ------- -------- ----------- ----------- --------- ------- ------------ ----------
  hiv      chr11     \+     63052973    68240744    5187771   6.73    1.16e-052      177
  hiv      chr6      −      29857643    34003291    4145648   25.59   7.53e-046      171
  hiv      chr16     −          0        3573133    3573133   9.82    1.85e-045      171
  hiv      chr11     −      63408683    68252636    4843953   5.23    6.59e-045      169
  hiv      chr6      \+     29653216    33939640    4286424   31.23   2.42e-043      179
  hiv      chr16     \+         0        3106569    3106569   13.06   3.32e-042      153
  hiv      chr1      \+         0        4770330    4770330   14.32   1.66e-027       89
  hiv      chr3      −      46696908    53554160    6857252   4.03    1.58e-025      159
  hiv      chr17     −      70567573    74031223    3463650   4.35    1.14e-024       81
  hiv      chr17     \+     77083925    78700791    1616866   8.53    2.45e-024       56
  hiv      chr9      \+     136302969   140273252   3970283   7.96    4.03e-023       97
  hiv      chr1      −      151528646   154707353   3178707   4.77    4.52e-020      114
  hiv      chr9      −      135483396   140273252   4789856   6.70    1.62e-019      105
  hiv      chr3      \+     46805137    51013082    4207945   3.78    1.18e-014      101
  hiv      chr1      \+     152393200   155051471   2658271   3.61    1.36e-014       97
  hiv      chr8      \+     143266499   146274826   3008327   5.29    1.76e-013       94
  hiv      chr17     −      76476613    78537508    2060895   4.42    1.85e-013       67
  hiv      chr2      −      26376098    28509807    2133709   5.32    4.64e-013       51
  hiv      chr8      −      142937251   146274826   3337575   5.58    7.07e-013       94
  hiv      chr17     \+     71000437    72361727    1361290   5.03    2.53e-012       50
  mlv      chr18     \+     71458533    76117153    4658620   14.38   1.65e-011       17
  mlv      chr21     −      38477753    39470763    993010    23.96   1.13e-010       5
  hiv      chr22     \+     48573053    49691432    1118379   6.34    8.99e-010       38
  hiv      chr20     −      60274607    62435964    2161357   6.34    8.99e-010       60
  mlv      chr17     \+     51301476    53344785    2043309   15.10   5.64e-009       12
  hiv      chr4      −          0        3791201    3791201   4.67    1.23e-008       61
  hiv      chr16     \+     86724460    88827254    2102794   4.08    3.24e-008       45
  mlv      chr20     \+     51190248    52356969    1166721   13.94   5.88e-008       6
  hiv      chr19     \+     54403063    55308772    905709    5.97    7.82e-008       47
  mlv      chr12     \+     115324321   117477353   2153032   10.89   1.10e-007       16
  mlv      chr6      −       5956453     7313927    1357474   33.96   1.20e-007       6
  hiv      chr2      \+     26617223    28096371    1479148   3.50    1.34e-007       47
  hiv      chr19     −      54293977    55393350    1099373   5.65    4.17e-007       54
  hiv      chr22     −      48767773    49691432    923659    4.40    4.85e-007       33
  hiv      chr2      −      185808293   188459285   2650992   8.25    5.51e-007       7
  mlv      chr18     −      71648647    73379689    1731042   10.02   1.04e-006       5
  hiv      chr12     \+     47052128    48977359    1925231   4.53    1.39e-006       53
  hiv      chr15     \+     38942654    41945536    3002882   3.80    2.97e-006       61
  mlv      chr20     −      51173685    52422011    1248326   9.58    3.17e-006       6
  mlv      chr3      \+     70940451    72487606    1547155   9.36    5.55e-006       4

List of the 40 top hotspots for which the p-value (Bonferroni-Holm adjusted [@pcbi.1002292-Holm1]) of the odds ratio (OR) being equal to one, was below 0.05. The first column indicates which virus had most integrations. Columns 2--5 locates the hotspot on its chromosome. Column 6 contains the width of the hotspot (min: 211313 bp, max: 6857252). The OR (column 7) was always defined to be larger than 1 (min: 2.24, max: Inf). The adjusted p-values are in column 8. The number (\#) of genes included in each hotspot is in the last column (range: 1 to 179). Full table is available in supplementary material [Table S1](#pcbi.1002292.s009){ref-type="supplementary-material"}.

doi:10.1371/journal.pcbi.1002292.t001

The length of the hotspots varies between ca. 200,000 bp and 7,000,000 bp, but most are longer than 10^6^ bp. They include between 1 and 179 genes. Of the 100 significative comparative hotspots, 49 have a higher density of HIV integrations (lengths ranging between 378,200 and 6,857,000 bp; median: 2,651,000 bp, 2,027 unique target genes) while 51 contain a higher MLV density (lengths ranging between 211,300 and 6,021,000 bp; median: 1,319,000 bp, 475 unique target genes). The median length of MLV hotspots is about the half of the median length of HIV hotspots with a significative difference (p-value: 2.108•10^−06^; Mann-Whitney test, p-values computed by permutations). The wideness of HIV hotspots only partially accounts for the higher number of target genes compared to MLV (2,027 *vs.* 475), as shown by plotting the number of targets per hotspot normalized by the hotspot length (see [Figure 3](#pcbi.1002292-g003){ref-type="fig"}: p-value = 1.953\*10^−8^, Mann-Whitney test, p-values computed by permutations). This hints at gene density as a critical parameter for HIV integration site selection and is in accordance with the recent finding that MLV integration is associated to transcription regulatory regions rather than to genes [@pcbi.1002292-Felice1],[@pcbi.1002292-Cattoglio2],[@pcbi.1002292-Biffi1].

![**Gene density of HIV and MLV comparative hotspots.**\
Histogram of the number of target genes per hotspot normalized by hotspot length in HIV (blue bars, upper panel) and MLV (red bars, lower panel).](pcbi.1002292.g003){#pcbi.1002292-g003}

To investigate the categories of genes preferentially targeted by the comparative hotspots we performed a Gene Ontology (GO) classification of HIV and MLV target genes (supplementary material, [Table S2](#pcbi.1002292.s010){ref-type="supplementary-material"}). Among the 2,027 genes in the comparative hotspots with HIV preference, the analysis showed a significant enrichment over the background (0.005\<p-values\<0.05, Fischer\'s exact test with Bonferroni correction for multiple testing) for genes involved in antigen processing and presentation, and in hormone nuclear receptor activity. Remarkably, both GO terms exclusively contained genes located in the MHC locus on chromosome 6 (highest peak in [Figure 1](#pcbi.1002292-g001){ref-type="fig"}). Among the 475 MLV targets, genes participating in adaptive immune response, signal transduction, and regulation of biological processes were over-represented (0.005\<p-values\<0.05). Differently from HIV targets, these genes did not belong to the same chromosomal region.

The annotation of oncogenes [@pcbi.1002292-Futreal1] (Sanger Cancer Gene Census, <http://www.sanger.ac.uk/genetics/CGP/Census>) incorporated into comparative hotspots (see the full gene [Table S1](#pcbi.1002292.s009){ref-type="supplementary-material"} in supplementary material) did not reveal a significant difference in the targeting frequency between the two vectors, both when considering all genes (0.045 for HIV *vs.* 0.050 for MLV, p-value: 0.4109) or the sole genes in the 100 significative comparative hotspots (0.047 for HIV *vs.* 0.054 for MLV, p-value: 0.06707). We next investigated the relation between gene expressions and comparative integration hotspots. We compared the frequency of expressed genes belonging to comparative integration hotspots with the frequency of transcribed genes located elsewhere in the genome. After multiple testing corrections, we found just one hotspot with increased presence of expressed genes with respect to the genomic baseline (hiv_55, adjusted p-value 0.02800; see [Table S1](#pcbi.1002292.s009){ref-type="supplementary-material"}, supplementary material for full results). Three comparative hotspots, all with higher MLV density (mlv_50, mlv_51, mlv_124, p-values: 0.00075, 00.00197, 0.00778 respectively), showed instead a reduced presence of expressed genes.

Since there is strong evidence of association between integration sites and specific histone modifications [@pcbi.1002292-Biasco1],[@pcbi.1002292-Wang1],[@pcbi.1002292-Cattoglio3], we also investigated the histone methylation [@pcbi.1002292-Cui1] density in comparative hotspots, defined as the methylation intensities (i.e., the number of ChIP-seq reads) in each comparative hotspot, divided by the hotspot length; the same was done for the histone variant H2A.Z. We compared the mean density of histone modifications associated to transcription or heterochromatin in HIV vs. MLV hotspots using the Welch statistic test, which does not assume the same variance for the two groups, with p-values computed by permutations. After adjustment for multiplicity (Bonferroni-Holm) three methylations and the one histone variant analyzed were found to have different mean density in HIV vs. MLV hotspots (H3K4me1, H3K4me3, H3K9me1, H2AZ; adjusted p-values: 0.000096, 0.000010, 0.020986, 0.000018 respectively). Results are summarized in [table 2](#pcbi.1002292-t002){ref-type="table"}.

10.1371/journal.pcbi.1002292.t002

###### Density of histone modifications in comparative hotspots.

![](pcbi.1002292.t002){#pcbi-1002292-t002-2}

  methylation      HIV        MLV         p       adjusted-p             
  ------------- ---------- ---------- ---------- ------------ ---------- --------------
  H3K27me3       0.002805   0.001179   0.003140    0.001585    0.069324     0.347210
  **H2AZ**       0.003625   0.001441   0.004494    0.001444     2e-06     **0.000018**
  H3K27me1       0.003399   0.000889   0.003774    0.001235    0.008568     0.050412
  H3K36me3       0.006188   0.005843   0.005998    0.003063    0.766001        1
  **H3K4me1**    0.002469   0.001630   0.003486    0.001823     6e-06     **0.000096**
  **H3K4me3**    0.001617   0.001179   0.001078    0.000494     1e-06     **0.000010**
  **H3K9me1**    0.006676   0.004553   0.008585    0.005302    0.00297    **0.020986**
  H3K9me3        0.003696   0.003790   0.003555    0.001467    0.728885        1
  H4K20me1       0.008214   0.005921   0.007407    0.004374    0.212219     0.846512
  PolII          0.001876   0.000829   0.002016    0.001054    0.263484     0.846512

Columns 2 and 3 report the mean density of modifications and relative standard deviation in comparative hotspots with HIV abundance. Columns 4--5 are mean density and standard deviation in MLV preferred hotspots. The p-values for the equality of the means are in column 5 (Mann-Whithney test statistics, p-values computed by permutations) and adjusted p-values in column 6 (Bonferroni-Holm method). In bold, methylations/histone variants with significative difference.

doi:10.1371/journal.pcbi.1002292.t002

The construction of the variability bands of an integration density depends on a design smoothing parameter, as described in the [Materials and Methods](#s4){ref-type="sec"} section. The choice of such smoothing parameters controls the regularity of the variability bands and therefore had an effect on the comparison. We estimated the smoothing parameters in an optimal fashion (in correspondence to which results were reported), but also studied robustness of the hotspots by varying them systematically. We systematically checked if a comparative hotspot would have persisted for larger and smaller smoothing parameters. [Figure 4](#pcbi.1002292-g004){ref-type="fig"} shows the results of such a sensitivity study for two strands of chromosome 6. The middle line, corresponding to 1, shows the hotspot identified by the two optimal smoothing parameters, while above and below that we see how hotspots would grow and shrink by increasing and reducing the smoothing level. It is important that the chosen segments at level 1 continue to appear for values just above and under, as happened systematically. This visual inspection strengthens the validity of the way we chose the smoothing parameters. See [Methods](#s4){ref-type="sec"} for more details and supplementary material [Figures S3](#pcbi.1002292.s003){ref-type="supplementary-material"}, [S4](#pcbi.1002292.s004){ref-type="supplementary-material"}, [S5](#pcbi.1002292.s005){ref-type="supplementary-material"}, [S6](#pcbi.1002292.s006){ref-type="supplementary-material"}, [S7](#pcbi.1002292.s007){ref-type="supplementary-material"} and [S8](#pcbi.1002292.s008){ref-type="supplementary-material"} for robustness plots for all chromosomes.

![**Robustness plots.**\
Panel A: chromosome 6, arm p; strand -. Panel B: chromosome 6, arm q; strand -. Here we can observe how hotspots would change in length and location if we were to use different smoothing parameters. Most importantly, we see that the hotspots identified at level 1, corresponding to our choice of the smoothing parameters, persist at slightly larger and smaller values, confirming their validity. At smaller levels of smoothing many spurious hotspots appear, of very short length. There is no support from the data for these, as they either disappear for more smoothing or they merge into larger and more robust segments. Large smoothing either impairs the creation of hotspots (as bands tend to become large and flat) or they deliver very large hotspots, which are difficult to interpret biologically.](pcbi.1002292.g004){#pcbi.1002292-g004}

Discussion {#s3}
==========

Integration of MLV-derived retroviral vectors may have significant consequences on gene expression and homeostasis of transduced and transplanted target cells, particularly in the hematopoietic system. The enhancer activity of the MLV LTRs may de-regulate proto-oncogenes, and cause pre-neoplastic clonal expansion [@pcbi.1002292-Ott1],[@pcbi.1002292-Stein1], leukemic transformation without clonal expansion [@pcbi.1002292-HaceinBeyAbina2],[@pcbi.1002292-Howe1],[@pcbi.1002292-Wang2], or no apparent adverse effect [@pcbi.1002292-Aiuti1] depending on the disease context and a number of still ill-defined factors. Integration sites can be used as markers of clonality to study the clonal dynamics of transduced cells *in vivo*, and provide important clues to predict the potential genotoxicity of MLV integration in a specific cell or disease context [@pcbi.1002292-Wang2],[@pcbi.1002292-Deichmann1],[@pcbi.1002292-Schwarzwaelder1],[@pcbi.1002292-Aiuti2],[@pcbi.1002292-Wang3]. We used LM-PCR and pyrosequencing to derive high-definition maps of MLV and HIV integration sites in the genome of human CD34^+^ hematopoietic progenitors. As previously reported [@pcbi.1002292-Ambrosi2], MLV integrations were clustered around gene regulatory elements (promoters, enhancers, evolutionarily conserved non-coding regions) bearing epigenetic marks of active transcription (H3K4me1, H3K4me2, H3K4me3, H3K9Ac) and specialized chromatin configurations (H2A.Z). On the contrary, HIV integrations occurred away from regulatory elements, and are associated with histone modification enriched in the body of transcribed genes (H3K36me3 and H2BK5me1). In both cases, statistical analysis identified hotspots of clustered integrations with strong correlation with transcriptional activity, using random integration datasets as controls.

In this study, we identify broad areas of the genome where HIV and MLV integrate differently; therefore it was not expected to find comparative hotspots in areas of high gene expression. This is in accordance with the fact that a single hotspot showed an increased expression level with respect to the rest of the genome. We used non-parametric density estimation and variability bands to identify regions of the genome as candidate comparative, i.e., virus-specific, hotspots. Thereafter, these were tested for significance. The first step delivers a series of bins, of variable length, were the two integration frequencies appear to be different. This strategy is more effective than binning the chromosome with equal size bins, since some of them might not be large enough to contain enough integrations. An optimal bin size algorithm, producing a constant bun size, would easily divide a chromosome in a dozen bins, which would be too large to be of practical interest as candidate hotspots. Our approach generates a list of bins of variable and adaptive length, only in areas of interest. Interestingly, this analysis identified large genomic regions (0.2 to \>6 Mb in length) rather than local (\<100 kb) hotspots. Most genomic regions are targeted by both virus types, most likely because they contain a high proportion of active genes and regulatory elements. Some regions, however, are targeted by either virus in a specific fashion, where HIV-specific hotspots tend to be larger in size and to contain more genes. The expression and gene ontology characteristics of the genes contained in MLV and HIV-specific regions, however, were comparable, and there are no obvious characteristics that would predict such a striking virus-specific preference. While MLV-specific regions are enriched for histone modifications/variants correlated with active regulatory regions (H3K4me1, H2A.Z), HIV-specific regions have a higher density of H3K4me3, associated to active transcription start sites. Although counterintuitive, given the well-known MLV preference for transcription start sites, this might be simply explained by the higher gene content of HIV-specific hotspots. Unfortunately, genomic distribution of HIV tethering factors, such as LEDGF/p75, is not known, particularly for hematopoietic progenitors, and it is therefore impossible to test whether high protein concentration in specific chromosomal region may explain the HIV-specific preferences.

Interestingly, we found a significant comparative hotspot spanning the entire MHC locus on chromosome 6 (from the MHC class I to the extended MHC class II subregions [@pcbi.1002292-Horton1]) with increased HIV, but not MLV, integration propensity. Importantly, a gene-centric hotspot definition would have failed to detect this locus, since in this particular case intergenic regions rather than single genes are highly targeted by HIV.

Large, virus-specific hotspots may suggest that tethering of PICs to chromatin favors relatively wide chromosomal territories independently from their content or local concentration of "attractive" features, such as GC content of DNA, binding of factors or transcriptional complexes, nucleosome density or epigenetic marks. This type of preference may instead reflect larger scale, nuclear topology factors that make these regions more accessible to one or another virus type. The modalities by which HIV and MLV access target cell chromatin, may be a critical factor underlying these preferences. MLV is incapable of entering intact nuclei and requires cell division in order to integrate, while HIV is actively imported in interphase nuclei through the nuclear pores. MLV and HIV PICs therefore "see" chromatin in different phases of the cell cycle, and may have access to different regions simply because they are differently exposed. Recent studies showed that alterations in the nuclear pore architecture impairs HIV nuclear import and impacts on integration efficiency, suggesting that access to chromatin is mediated by the nuclear pore and may be a critical component of target site selection [@pcbi.1002292-Matreyek1],[@pcbi.1002292-Ocwieja1]. The HIV-specific hot regions identified in this study may therefore reflect the chromatin organization in the vicinity of the nuclear pore. Studies are in progress to test this hypothesis in clinically relevant target cells.

Materials and Methods {#s4}
=====================

Integration Within Cd34^+^ Cells {#s4a}
--------------------------------

We worked with a previously published collection of 28,382 HIV and 32,631 MLV retroviral integration sites isolated by linker-mediated PCR (LM-PCR) and pyrosequenced by GS-FLX Genome Sequencer (Roche/454 Life Sciences, Branford, CT) from cord blood-derived human CD34^+^ hematopoietic stem-progenitor cells [@pcbi.1002292-Cattoglio2]. The bioinformatics pipeline used to process crude MLV and HIV sequence reads was previously described [@pcbi.1002292-Cattoglio2]. Briefly, valid reads 20-bp or longer were used to generate a non-redundant dataset using the nrdb tool (available at <http://www.advbiocomp.com/blast.html> in the AB-BLAST software package). Non-perfectly redundant reads were than mapped onto the human genome, requiring the alignment to start within the first three nucleotides and to possess a minimum of 90% identity. Sequences were discarded when mapping to multiple sites if they had more than one match on the human genome differing in identity less than 2%. Overall valid sequence recovery was similar between MLV and HIV (13.3% and 17.3%, respectively). The expression profile of CD34^+^ cells was determined by microarray analysis of cytokine-activated cells from three independent umbilical cords. RNA was extracted from 1--2×10^6^ cells, transcribed into biotinylated cRNA and hybridized to Affymetrix HG-U133A plus 2.0 Gene Chip arrays.

Functional Clustering Analysis {#s4b}
------------------------------

Functional clustering of target genes was performed by the DAVID 2.0 Functional Annotation Tool and EASE score, as previously described [@pcbi.1002292-Cattoglio1]. GO categories were considered over-represented when yielding an EASE score \<0.05, after Bonferroni-Holm correction for multiple testing.

Blind Regions {#s4c}
-------------

Certain areas of the genome cannot be scanned in order to investigate the presence of integrations. This is mainly due to two reasons: genome mappability and the presence of what we call "blind regions". Although extremely critical in determining the randomness of single integration patterns, genome mappability was not a concern in our comparative study, since only unequivocally mapping reads were considered, for the comparison of MLV and HIV integration patterns (*i.e.*, the mappability bias, if any, was the same for the two vectors). Blind regions instead derive from the use of restriction enzymes and size-selection during the integration library preparation, and represent portions of the genome that are scarcely accessible to detection due to their distance to the closest 3′ restriction site ([Figure 5](#pcbi.1002292-g005){ref-type="fig"}). Specifically, if this distance is shorter than the sensibility of alignment programs, in terms of minimum length of the processable sequence, integration is not identifiable. For example, if a viral vector integrated 10 bps far from the closest 3′ cut sequence, then from the sequencing platform we obtained a 10 bps sequence, that for most of alignment program is not processable. We used Blat [@pcbi.1002292-Kent1] which has minimum sequence length of 20 nt. On the other hand, the size-fractionation step only includes fragments \<500 nt, this being the maximum estimated length for efficient 454 bead loading (see supplemental methods in [@pcbi.1002292-Cattoglio1]). Therefore, integrations with a distance to the closest 3′ restriction enzyme site of, for example, 600 bps, would not be detected. These blind regions need to be excluded from further analysis, as it was impossible to determine accurately integration frequencies occurring therein. We first identified these blind regions by looking for the position of restriction sequences over the whole genome. We then cut off the blind regions. When performing density estimation, we skipped blind regions and connected together successive non-blind parts. We assumed smoothness of the density at mending points, as the blind regions were comparably short. Once hotspots were found, the blind areas were placed back in the original topology. Integration analysis was performed separately for each chromosomal arm, so that it was not affected by the centromere, which is a giant blind region. Furthermore, we studied separately each strands, since blind regions are strand specific. The presence of blind regions due to the restriction enzyme digestion is known. It has been shown that the "invisible" portion of the genome is substantially affected by the use of different and/or multiple restriction enzymes [@pcbi.1002292-Gabriel1]. We also found the percentage of blind regions to be very significant, ranging from 10% up to 40% of the length of the chromosome. For example, 30.5% of chromosome 1 was blind (total length 247.249.719 bp); see supplementary material [Table S1](#pcbi.1002292.s009){ref-type="supplementary-material"} for percentages for all chromosomes. Blind regions were identified by means of a custom R-script (R ver 2.10 [@pcbi.1002292-Team1] and Bioconductor [@pcbi.1002292-Gentleman1]) which searched for the TTAA sequences (MseI) on the Hg18 UCSC genome. Once occurrences were identified, blind regions were estimated as follows: from TTAA to 20 bp downstream (due to algorithm limitation) and from 500 bp downstream to the consecutive restriction site (due to deep sequencing platform limitation).

![**Blind regions.**\
These plots illustrate the presence of blind regions, which are scattered over the genome and usually short, but occasionally also of appreciable length (panel A: mlv_53, chromosome 7, arm p strand -; panel B: mlv_147, chromosome 22 arm q, strand +). Not all the candidate comparative hotspots that we identified were clearly distinguishable, see for example panel A.](pcbi.1002292.g005){#pcbi.1002292-g005}

Statistics {#s4d}
----------

The integration dynamics was modelled as a stochastic process, where integration points were considered as samples from an unknown density function on the region of study *D*. We assumed that each integration was independent of any other. Each virus was considered as a random variable *v* with its own unknown probability density function . Comparing integration preferences of two viruses *v~1~* and *v~2~* was then turned into the statistical problem of comparing two unknown densities and , defined on the same genomic range *D*, based on an independent and identically distributed sample from each of the two densities. The samples were allowed to have different sample size. Our approach was fully nonparametric and led to candidate comparative hotspots, which were then individually tested. Specifically, non-parametric kernel density estimation with Gaussian kernels was used [@pcbi.1002292-Wand1]. In a basepair , the estimated density , based on the sample in *D*, is given by the kernel density estimatorwhere *K*(·) is the kernel and *h*\>0 is the smoothing parameter (bandwidth). We used the Gaussian kernelNotice the scaling of the kernel with *h*, which controls how much weight each integration *x~i~* has in the estimate at a basepair *x*. We performed a small approximation, as the kernel should integrate to 1 over *D*, and the domain *D* is discrete. However, the resolution at basepair level of the chromosome arms is extremely high, so that the effect of this was negligible.

We wished to construct simultaneous confidence bands (at 0.99 level, say) for the two densities to be compared, in order to identify areas (if any) where the confidence bands did not overlap: in such segments of *D*, one density must clearly be below the other. However, such confidence bands depend on the second derivative of the unknown density, controlling both bias and variance; approximations are available only in some special cases under very strong conditions. We instead calculated pointwise variability bands around the estimated densities, where the variation in the density estimates were taken into account, but the bias was ignored. The segments of the chromosome *D* where the two variability bands had empty intersection were considered as candidate comparative hotspots. The 0.99 variability band for the estimated density was computed [@pcbi.1002292-Azzalini1] starting with the Taylor expansionwhereis the integral of the squared kernel function and n is the sample size. The root transform allowed obtaining an approximation of the variance which was independent from the unknown density. Therefore, on the square root scale, a level error band could be computed, using the half widtharound the squared root of the estimate, where is the quantile of the normal standard distribution. Then, as in [@pcbi.1002292-Azzalini1], the edges of this band were transformed back to the original scale aswhere the lower bound is set to zero if it took a negative value. We used .

This is not a confidence band and there is no nominal coverage probability. The effect of the bias is to diminish modes and fill valleys, as it depends on the curvature of (and on the bandwidth), see [@pcbi.1002292-Azzalini1]. Variability bands of this type were computed for both densities. Typically, a detected candidate comparative hotspot (where the two variability bands had empty intersection) resulted from a pronounced peak in one density and a valley or flat area in the other. In these situations, adjusting for the bias would have strengthened further the indication of a hotspot. On the other hand, the absence of bias adjustment could in some special situations hide a difference. This indicates that in most cases we have identified candidate comparative hotspots conservatively.

We compared the two pointwise variability bands at level , one for each virus, to detect where the bands did not overlap. These segments in *D* were considered as candidate comparative hotspots. This approach is different from [@pcbi.1002292-Sandve1], where bins are decided in advance, instead than being data-driven.

Though the band was computed pointwise, it inherited smoothness from the smooth density estimate around which it was built. For computational efficiency, the density was estimated on a grid of points, which were then interpolated with a spline function [@pcbi.1002292-Hastie1]. We did not implement any particular boundary control at the border of the chromosome arm not flanking the centromere.

The choice of the smoothing parameters *h* ~1~ and *h* ~2~, one for each viral integration density, is important: too much smoothing would flatten the kernel estimates, hiding every difference; too little smoothing would lead to a too rich and fragmented identification of comparative hotspots, with very high false positive findings. Our choice was to perform an automatic and optimal choice of the smoothing parameter for each density and then study how results would change when this value was perturbed in both directions, towards more and towards less smoothing. We chose the optimal smoothing parameters, *h* ~opt~, one for each density, using unbiased cross-validation [@pcbi.1002292-Sheater1]. Briefly, *h* ~opt~ is chosen to minimize the measure of closeness of to given by the Integrated Squared Errorthrough a least square, leave-one-out crossvalidation criterion. For this purpose we minimized the estimate of the first two terms of the ISE (the last term does not depend on *h*) given bywhere denotes the kernel estimator constructed from the data without the observation . See [@pcbi.1002292-Sheater1],[@pcbi.1002292-Scott1] for more details. In order to test sensitivity of results with respect to the choice of *h*, we reparameterized the smoothing parameter as *h* = *h* ~opt~ *s*, where the sensitivity factor *s* was left to vary in \[0.05, 20\]. We then repeated the comparison of the variability bands for the two viral integration densities, using the crossvalidated optimal smoothing parameter for each virus, adjusted with the same *s*. We plotted the comparative hotspots while varying *s*, to see the robustness of each hotspot, as in [Figure 4](#pcbi.1002292-g004){ref-type="fig"}.

Candidate comparative hotspots were then tested individually, to confirm (or not) that the integration propensities of the two viruses were significantly different. As many comparisons were performed, multiple testing correction was done. We computed the odds ratio of the two integration intensities, one for each virus, for each candidate hotspot aswhen HIV had a higher density and the inverse of it when the MLV density was higher instead. Here is the number of integration of HIV falling inside the candidate hotspot *H*, is the number of integration outside hotspot *H*, and similarly for MLV. We computed 0.95 confidence intervals for this odds ratio and tested the null hypothesis that the odd ratio is 1. We used the Fisher exact test. Raw p-values were then corrected for multiple testing by Bonferroni-Holm [@pcbi.1002292-Holm1]. All computations and analyses were performed in R and Bioconductor environment [@pcbi.1002292-Team1],[@pcbi.1002292-Gentleman1].

Supporting Information {#s5}
======================

###### 

**Integration densities of HIV and MLV in CD34^+^ cells, for chromosomes chr1, chr2, chr3, chr4, chr5, chr6, chr7, chr8, chr9, chr10, chr11 and chr12.** We analyzed each strand separately: the upper half is the+strand and the lower the−strand. In blue the estimated variability band at level 0.99 for HIV integrations, in red for MLV. Candidate comparative hotspots are plotted in the two central *x*-axes, the color indicating which of the two vectors had stronger integration intensity (HIV: blue; MLV: red). In the other four *x*-axes, each tick represents one integration site, with the same color code. Because of resolution, many ticks fall on the same point and cannot be distinguished.

(TIFF)

###### 

Click here for additional data file.

###### 

**Integration densities of HIV and MLV in CD34^+^ cells, for chromosomes chr13, chr14, chr15, chr16, chr17, chr18, chr19, chr20, chr21, chr22, chrX and chrY.** We analyzed each strand separately: the upper half is the+strand and the lower the−strand. In blue the estimated variability band at level 0.99 for HIV integrations, in red for MLV. Candidate comparative hotspots are plotted in the two central *x*-axes, the color indicating which of the two vectors had stronger integration intensity (HIV: blue; MLV: red). In the other four *x*-axes, each tick represents one integration site, with the same color code. Because of resolution, many ticks fall on the same point and cannot be distinguished. Since no integration was found in p-arm of chromosomes chr13, chr14, chr15, chr21 and chr22, in such cases only the q-arm was plotted.

(TIFF)

###### 

Click here for additional data file.

###### 

**Robustness plots for all hotspots, chromosomes chr1, chr2, chr3 and chr4.** The name of each figure identifies the chromosome and the arm and strand. In these figures we can observe how hotspots would change in length and location if we were to use different smoothing parameters. Most importantly, we see that the hotspots identified at level 1, corresponding to our choice of the smoothing parameters, persist at slightly larger and smaller values, confirming their validity. At smaller levels of smoothing many spurious hotspots appear, of very short length. There is no support from the data for these, as they either disappear for more smoothing or they merge into larger and more robust segments.

(TIFF)

###### 

Click here for additional data file.

###### 

**Robustness plots for all hotspots, chromosomes chr5, chr6, chr7 and chr8.** The name of each figure identifies the chromosome and the arm and strand. In these figures we can observe how hotspots would change in length and location if we were to use different smoothing parameters. Most importantly, we see that the hotspots identified at level 1, corresponding to our choice of the smoothing parameters, persist at slightly larger and smaller values, confirming their validity. At smaller levels of smoothing many spurious hotspots appear, of very short length. There is no support from the data for these, as they either disappear for more smoothing or they merge into larger and more robust segments.

(TIFF)

###### 

Click here for additional data file.

###### 

**Robustness plots for all hotspots, chromosomes chr9, chr10, chr11 and chr12.** The name of each figure identifies the chromosome and the arm and strand. In these figures we can observe how hotspots would change in length and location if we were to use different smoothing parameters. Most importantly, we see that the hotspots identified at level 1, corresponding to our choice of the smoothing parameters, persist at slightly larger and smaller values, confirming their validity. At smaller levels of smoothing many spurious hotspots appear, of very short length. There is no support from the data for these, as they either disappear for more smoothing or they merge into larger and more robust segments.

(TIFF)

###### 

Click here for additional data file.

###### 

**Robustness plots for all hotspots, chromosomes chr13, chr14, chr15 chr16 and chr17.** The name of each figure identifies the chromosome and the arm and strand. In these figures we can observe how hotspots would change in length and location if we were to use different smoothing parameters. Most importantly, we see that the hotspots identified at level 1, corresponding to our choice of the smoothing parameters, persist at slightly larger and smaller values, confirming their validity. At smaller levels of smoothing many spurious hotspots appear, of very short length. There is no support from the data for these, as they either disappear for more smoothing or they merge into larger and more robust segments. Since no integration was found in p-arm of chromosomes chr13, chr14 and chr15 in such cases only the q-arm was plotted.
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###### 

Click here for additional data file.

###### 

**Robustness plots for all hotspots, chromosomes chr18, chr19, chr20, chr21 and 22.** The name of each figure identifies the chromosome and the arm and strand. In these figures we can observe how hotspots would change in length and location if we were to use different smoothing parameters. Most importantly, we see that the hotspots identified at level 1, corresponding to our choice of the smoothing parameters, persist at slightly larger and smaller values, confirming their validity. At smaller levels of smoothing many spurious hotspots appear, of very short length. There is no support from the data for these, as they either disappear for more smoothing or they merge into larger and more robust segments. Since no integration was found in p-arm of chromosomes chr21 and 22 in such case only the q-arm was plotted.

(TIFF)

###### 

Click here for additional data file.

###### 

**Robustness plots for all hotspots, chromosomes chrX and chrY.** The name of each figure identifies the chromosome and the arm and strand. In these figures we can observe how hotspots would change in length and location if we were to use different smoothing parameters. Most importantly, we see that the hotspots identified at level 1, corresponding to our choice of the smoothing parameters, persist at slightly larger and smaller values, confirming their validity. At smaller levels of smoothing many spurious hotspots appear, of very short length. There is no support from the data for these, as they either disappear for more smoothing or they merge into larger and more robust segments.

(TIFF)

###### 

Click here for additional data file.

###### 

**Comparative Hotspots.** List of the hotspots. The first column indicates the hotspot ID. Column 4 shows which virus had most integrations. Columns 2,3,5,6,7 locates the hotspot on its chromosome. Column 8 and 9 contain the number of integrations. Column 10 contains the width of the hotspot. The OR (column 11) was always defined to be larger than 1. The confidence interval, raw p-values and adjusted p-values are in columns 12--15. The number of genes included in each hotspot is in column 16. The Proto Oncogenes founded in each hotspot is in columns 17. The number of Proto Oncogenes and their density with respect the number of genes in each hotspots are reported in columns 18--19. Number of present and absent genes are in columns 20--21. OR of the present vs absent genes, OR confidence interval, raw p-value and adjusted p-values are reported in columns 22--26.

(XLS)

###### 

Click here for additional data file.

###### 

**Gene Ontology (GO) analysis of genes targeted by HIV and MLV comparative hotspots.** 2027 and 475 genes targeted by HIV and MLV comparative hotspots were analyzed by the DAVID Functional Annotation tool [@pcbi.1002292-Aiuti1],[@pcbi.1002292-HaceinBeyAbina1], using the Human Genome as a background population. The table summarizes the significantly over-represented GO categories (GO terms) in the two datasets, after Bonferroni correction for multiple testing. The number of genes included in each GO category is specified (Count), together with their percentage (%) with respect to the total number of genes in the list (List Total) and the fold enrichment over the background. The GO class to which each category belongs is also given (BP: biological process, MF: molecular function, CC: cellular compartment).

(DOC)

###### 

Click here for additional data file.
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